prostate-cancer

Documents about prostate-cancer

• PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer#268019ClinicalTrials.gov
• Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy#424344ClinicalTrials.gov
• Prostate Cancer#486744Directory of Open Access Books
• Lifestyle Intervention in Patients With Metastatic Prostate Cancer#800590ClinicalTrials.gov
• HCQ in Resectable Localized Prostate Cancer#801962ClinicalTrials.gov
• Multiparametric Ultrasound-Study for the Detection of Prostate Cancer#803609ClinicalTrials.gov
• SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer#811369ClinicalTrials.gov
• Lycopene in Preventing Prostate Cancer in Healthy Participants#825396ClinicalTrials.gov
• PET/MRI for the Staging of Newly Diagnosed Prostate Cancer#825965ClinicalTrials.gov
• Prostate Biomarkers in Men Consuming Tomato Products#829625ClinicalTrials.gov
• Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer#824818ClinicalTrials.gov
• Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer#181729ClinicalTrials.gov
• Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer#411257ClinicalTrials.gov
• Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer#623492ClinicalTrials.gov
• ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer#801096ClinicalTrials.gov
• Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity#839354ClinicalTrials.gov
• A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer#801446ClinicalTrials.gov
• Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer#806917ClinicalTrials.gov
• Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer#832015ClinicalTrials.gov
• Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer#148747ClinicalTrials.gov
• Interstitial photodynamic therapy for primary prostate cancer incorporating realtime treatment dosimetry#785376Lund University Publications
• Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients#828062ClinicalTrials.gov
• MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer#811817ClinicalTrials.gov
• Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021#311114ClinicalTrials.gov
• Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients#366586ClinicalTrials.gov
• Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer#377408ClinicalTrials.gov
• The contribution of population-specific PRIM2 variants to prostate cancer#379036OpenUCT
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy#405162ClinicalTrials.gov
• ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer#803576ClinicalTrials.gov
• 68Ga-PSMA PET/CT in Prostate Cancer#825465ClinicalTrials.gov
• miRNA Panel for PCa Diagnosis#830765ClinicalTrials.gov
• A Safety and Feasibility Study of Mitotane in Prostate Cancer#837026ClinicalTrials.gov
• Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21#146264ClinicalTrials.gov
• Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer#287523ClinicalTrials.gov
• Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients#307421ClinicalTrials.gov
• Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy#825581ClinicalTrials.gov
• PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer#840536ClinicalTrials.gov
• Sex steroid hormones production in periprostatic adipose tissue and its role in prostate cancer progression#238937HAL (France)
• Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer#805793ClinicalTrials.gov
• Prostate Cancer Screening Trial Using Imaging#832741ClinicalTrials.gov
• Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer#844969ClinicalTrials.gov
• Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer#830287ClinicalTrials.gov
• Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma#844950ClinicalTrials.gov
• A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)#804918ClinicalTrials.gov
• Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer#813628ClinicalTrials.gov
• PROvenge Treatment and Early Cancer Treatment#208293ClinicalTrials.gov
• Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy#804192ClinicalTrials.gov
• A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy#842906ClinicalTrials.gov
• Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer#343709ClinicalTrials.gov
• Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer#839437ClinicalTrials.gov